Global Porcine Epidemic Diarrhea Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 105921
- Pages: 100
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Porcine Epidemic Diarrhea Vaccines market in this environment.
In terms of revenue, this research report indicated that the global Porcine Epidemic Diarrhea Vaccines market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Porcine Epidemic Diarrhea Vaccines industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The CAVAC aims at producing XX K Units Porcine Epidemic Diarrhea Vaccines in 2020, with XX % production to take place in global market, Green Cross Veterinary Products accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Porcine Epidemic Diarrhea Vaccines Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Porcine Epidemic Diarrhea Vaccines Market
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken Co., Ltd.
Qilu Animal Health
Zoetis
...
...
Major Type of Porcine Epidemic Diarrhea Vaccines Covered in Prudent Markets report:
Live Vaccines
Killed Vaccines
Application Segments Covered in Prudent Markets Market
Piglets
Adults Pigs
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Porcine Epidemic Diarrhea Vaccines Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Live Vaccines -Product Introduction and Major Manufacturers
1.1.2 Killed Vaccines -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Porcine Epidemic Diarrhea Vaccines Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Porcine Epidemic Diarrhea Vaccines Market
3.1.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Porcine Epidemic Diarrhea Vaccines Market
3.2.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Porcine Epidemic Diarrhea Vaccines Market
3.3.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Porcine Epidemic Diarrhea Vaccines Market
3.4.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Porcine Epidemic Diarrhea Vaccines Market
3.5.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Porcine Epidemic Diarrhea Vaccines Market
3.6.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Porcine Epidemic Diarrhea Vaccines Market
3.7.1 Top Companies leading Porcine Epidemic Diarrhea Vaccines Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Porcine Epidemic Diarrhea Vaccines Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Porcine Epidemic Diarrhea Vaccines Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Porcine Epidemic Diarrhea Vaccines Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Porcine Epidemic Diarrhea Vaccines Sales and Growth Rate (2021-2027)
5.2 Global Porcine Epidemic Diarrhea Vaccines Sales Value and Growth Rate (2021-2027)
6 Porcine Epidemic Diarrhea Vaccines Competitive Analysis
6.1 CAVAC
6.1.1 CAVAC Company Profiles
6.1.2 CAVAC Product Introduction
6.1.3 CAVAC Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Green Cross Veterinary Products
6.2.1 Green Cross Veterinary Products Company Profiles
6.2.2 Green Cross Veterinary Products Product Introduction
6.2.3 Green Cross Veterinary Products Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Harrisvaccines, Inc.
6.3.1 Harrisvaccines, Inc. Company Profiles
6.3.2 Harrisvaccines, Inc. Product Introduction
6.3.3 Harrisvaccines, Inc. Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Komipharm
6.4.1 Komipharm Company Profiles
6.4.2 Komipharm Product Introduction
6.4.3 Komipharm Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Nisseiken Co., Ltd.
6.5.1 Nisseiken Co., Ltd. Company Profiles
6.5.2 Nisseiken Co., Ltd. Product Introduction
6.5.3 Nisseiken Co., Ltd. Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Qilu Animal Health
6.6.1 Qilu Animal Health Company Profiles
6.6.2 Qilu Animal Health Product Introduction
6.6.3 Qilu Animal Health Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Zoetis
6.7.1 Zoetis Company Profiles
6.7.2 Zoetis Product Introduction
6.7.3 Zoetis Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 ...
6.8.1 ... Company Profiles
6.8.2 ... Product Introduction
6.8.3 ... Porcine Epidemic Diarrhea Vaccines Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
